Letter to the Editor

The Activity of Carotidynia Syndrome is Correlated with the Soluble Intracellular Adhesion Molecule-1 (sICAM-1) Level

Authors: Yoshinori Taniguchi, MD, Taro Horino, MD, PhD, Yoshio Terada, MD, PhD, Yosuke Jinnouchi, MD, PhD

Abstract

To the Editor:


Carotidynia is a syndrome characterized by unilateral neck pain, and was initially described by Fay in 1927.1 Clinical findings include tenderness over the carotid bifurcation and pain aggravated by movement of the neck without structural abnormalities.2 The symptoms normally have a short duration of about 2 to 4 weeks, suggesting that the disease is self-limited. However, the occurrence and pathophysiology of carotidynia are still unclear. Here, we discuss the associations between several biological markers and the disease activity of carotidynia.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1.Fay T. Atypical neuralgia. Arch Neurol Psychiatry 1927;18:309–315.
 
2.Classification and diagnosis criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia 1988;8 (suppl 7):1–96.
 
3.Amaravadi RR, Behr SC, Kousoubris PD, et al. [18F] Fluorodeoxyglucose positron-emission tomography-CT imaging of carotidynia. AJNR Am J Neuroradiol 2008;29:1197–1199.
 
4.Taniguchi Y, Horino T, Hashimoto K. Is carotidynia syndrome a subset of vasculitis? J Rheumatol 2008;35:1901–1902.
 
5.Ara J, Mirapeix E, Arrizabalaga P, et al. Circulating soluble adhesion molecules in ANCA-associated vasculitis. Nephrol Dial Transplant 2001;16:276–285.
 
6.Coll-vinent B, Vilardell C, Font C, et al. Circulating soluble adhesion molecules in patients with giant cell arteritis. Correlation between soluble intercellular adhesion molecule-1 (sICAM-1) concentrations and disease activity. Ann Rheum Dis 1999;58:189–192.
 
7.Furukawa S, Imai K, Matsubara T, et al. Increased levels of circulating intercellular adhesion molecule 1 in Kawasaki disease. Arthritis Rheum 1992;35:672–677.
 
8.Upton PD, Smith JG, Charnock DR. Histologic confirmation of carotidynia. Otolaryngol Head Neck Surg 2003;129:443–444.